Squarepoint
EXAS

Squarepoint’s Exact Sciences EXAS Stock Holding History

Squarepoint’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-793,505
Closed -$80.6M – 4457
2025
Q4 		$80.6M Buy
793,505
+749,318
+1,696% +$60.2M 0.09% 257
2025
Q3 		$2.42M Sell
44,187
-90,813
-67% -$4.54M ﹤0.01% 1938
2025
Q2 		$7.17M Buy
135,000
+71,524
+113% +$3.63M 0.01% 1254
2025
Q1 		$2.75M Buy
+63,476
New +$3.21M ﹤0.01% 1847
2024
Q3 		– Sell
-160,701
Closed -$9.07M – 4266
2024
Q2 		$6.79M Sell
160,701
-28,889
-15% -$1.59M 0.01% 1167
2024
Q1 		$13.1M Sell
189,590
-40,579
-18% -$2.57M 0.02% 844
2023
Q4 		$17M Sell
230,169
-82,395
-26% -$5.4M 0.03% 645
2023
Q3 		$21.3M Buy
312,564
+297,148
+1,928% +$25.2M 0.05% 428
2023
Q2 		$1.45M Sell
15,416
-5,416
-26% -$422K ﹤0.01% 1900
2023
Q1 		$1.41M Buy
20,832
+6,929
+50% +$445K 0.01% 1657
2022
Q4 		$688K Sell
13,903
-335,730
-96% -$13.7M ﹤0.01% 2086
2022
Q3 		$11.4M Buy
349,633
+230,523
+194% +$9.5M 0.06% 384
2022
Q2 		$4.69M Buy
+119,110
New +$6.37M 0.03% 710
2022
Q1 		– Sell
-48,528
Closed -$3.78M – 3038
2021
Q4 		$3.78M Buy
48,528
+7,810
+19% +$689K 0.01% 916
2021
Q3 		$3.89M Buy
40,718
+2,028
+5% +$214K 0.01% 892
2021
Q2 		$4.81M Buy
38,690
+32,120
+489% +$3.83M 0.02% 741
2021
Q1 		$866K Sell
6,570
-17,155
-72% -$2.35M 0.01% 1623
2020
Q4 		$3.14M Sell
23,725
-18,071
-43% -$2.19M 0.02% 693
2020
Q3 		$4.26M Sell
41,796
-45,602
-52% -$3.94M 0.06% 386
2020
Q2 		$7.6M Buy
87,398
+54,853
+169% +$4.38M 0.12% 235
2020
Q1 		$1.89M Sell
32,545
-22,586
-41% -$1.83M 0.05% 460
2019
Q4 		$5.1M Buy
55,131
+1,079
+2% +$94.9K 0.03% 499
2019
Q3 		$4.88M Buy
+54,052
New +$6.16M 0.04% 488
2019
Q2 		– Sell
-145,868
Closed -$12.6M – 2454
2019
Q1 		$12.6M Buy
145,868
+125,102
+602% +$10.6M 0.13% 178
2018
Q4 		$1.31M Buy
+20,766
New +$1.43M 0.02% 820
2018
Q3 		– Sell
-219,091
Closed -$13.1M – 2032
2018
Q2 		$13.1M Buy
+219,091
New +$11.8M 0.17% 163
2018
Q1 		– Sell
-82,007
Closed -$4.31M – 1816
2017
Q4 		$4.31M Buy
+82,007
New +$4.38M 0.08% 312
2017
Q3 		– Sell
-26,773
Closed -$947K – 1678
2017
Q2 		$947K Sell
26,773
-39,979
-60% -$1.23M 0.02% 741
2017
Q1 		$1.58M Buy
66,752
+12,458
+23% +$247K 0.04% 456
2016
Q4 		$725K Buy
+54,294
New +$877K 0.03% 632
2016
Q3 		– Sell
-38,743
Closed -$475K – 1081
2016
Q2 		$475K Sell
38,743
-104,457
-73% -$787K 0.03% 576
2016
Q1 		$965K Buy
143,200
+73,800
+106% +$472K 0.07% 394
2015
Q4 		$641K Buy
+69,400
New +$645K 0.07% 415

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Squarepoint's EXAS Position: Q1 2026 in Review

Squarepoint sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 793,505 shares — an estimated $80.6M sold.

Squarepoint first reported a position in EXAS in Q4 2015 and held it in 33 quarters. The position peaked at $80.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Squarepoint reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 793,505 Exact Sciences shares in Q1 2026, an estimated $80.6M.
  • Squarepoint first reported a position in Exact Sciences in Q4 2015 and held it in 33 quarters.
  • Squarepoint's Exact Sciences position peaked at $80.6M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.